(19)
(11) EP 4 680 233 A2

(12)

(88) Date of publication A3:
24.10.2024

(43) Date of publication:
21.01.2026 Bulletin 2026/04

(21) Application number: 24775471.6

(22) Date of filing: 15.03.2024
(51) International Patent Classification (IPC): 
A61K 31/395(2006.01)
A61K 31/498(2006.01)
A61K 31/404(2006.01)
A61K 31/33(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/4035; A61K 31/496; A61K 31/416; A61P 25/28
(86) International application number:
PCT/US2024/020265
(87) International publication number:
WO 2024/196799 (26.09.2024 Gazette 2024/39)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 17.03.2023 US 202363490878 P
06.10.2023 US 202363542973 P
08.11.2023 US 202363547819 P
02.02.2024 US 202463549054 P

(71) Applicant: Cognition Therapeutics, Inc.
Pittsburgh, PA 15203 (US)

(72) Inventors:
  • HAMBY, Mary
    Pittsburgh, Pennsylvania 15203 (US)
  • CAGGIANO, Anthony
    Pittsburgh, Pennsylvania 15203 (US)

(74) Representative: HGF 
HGF Limited 4th Floor, 1 City Square
Leeds LS1 2AL
Leeds LS1 2AL (GB)

   


(54) ISOINDOLINE COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASE